The Target Turnaround Is Real. Here's What Investors Should Know.

Source Motley_fool

Key Points

  • Target received a nearly $1 billion tariff refund, which boosted profits.

  • The company raised its EPS guidance after a stellar quarter.

  • 10 stocks we like better than Target ›

Target (NYSE: TGT) is meeting its targets and proving skeptics wrong, showing that the veteran retailer's turnaround is for real. The Minnesota-based business reported second-quarter earnings that blew past estimates. Here's what investors need to know.

First and foremost, tariffs played a substantial role in the earnings beat as a one-time refund boosted numbers. The refund totaled nearly $1 billion. Still, without the repayment from the federal government, the company's adjusted earnings per share (EPS) would have grown 20% from the same period last year. Revenue climbed 5.3% year over year to $26.5 billion, with digital sales growing an impressive 8.7%.

Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »

Target's logo on a red backdrop.

Image source: The Motley Fool.

The company also raised its full-year EPS guidance to a range of $9.90 to $10.90. Target's stock has risen 65% year to date as of Aug. 19.

Secondly, Target still has a long way to go. The retailer is well below its 2021 peak and is rebuilding a damaged reputation after boycotts and public backlash over its reversal of DEI initiatives. This quarter shows the company's efforts to lure back shoppers are actually working.

This is the second consecutive quarter of strong earnings, and now we're heading into back-to-school season and the holidays. If Target can continue to grow its digital presence and sales, the stock looks like a compelling buy. I'm cautiously optimistic that a strong fall and winter season could solidify Target's comeback.

Much of Target's turnaround story could ultimately unfold outside the retailer's control, however, as inflation and tariff pressures keep consumers' wallets lean.

Should you buy stock in Target right now?

Before you buy stock in Target, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Target wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $432,189!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,330,956!*

Now, it’s worth noting Stock Advisor’s total average return is 967% — a market-crushing outperformance compared to 212% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of August 22, 2026.

Catie Hogan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Target. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Elon Musk’s AI Startup Acquisition Fails to Land as Cognition Rebuffs SpaceX BuyoutSpaceX’s attempt to acquire artificial intelligence coding startup Cognition AI Inc. stalled without a deal, according to people familiar with the matter. The approach would have been SpaceX’s second
Author  Beincrypto
Aug 20, Thu
SpaceX’s attempt to acquire artificial intelligence coding startup Cognition AI Inc. stalled without a deal, according to people familiar with the matter. The approach would have been SpaceX’s second
placeholder
Eli Lilly Price Forecast: The Next Big Stock After Weight-Loss Drug Breakthrough?Eli Lilly is one of the most popular names today in America’s weight-loss and diabetes drug market. Its drugs delivered an average weight loss of 28.3% in a Phase 3 trial, approaching results historic
Author  Beincrypto
Aug 20, Thu
Eli Lilly is one of the most popular names today in America’s weight-loss and diabetes drug market. Its drugs delivered an average weight loss of 28.3% in a Phase 3 trial, approaching results historic
placeholder
MicroStrategy Erases 2-Month Loss as Crypto Stocks Rally: Is the Damage Over?Strategy, the company once called MicroStrategy (MSTR), rose 6.9% to $111.14 on Thursday afternoon. That is its best price since June 18, which wipes out a two-month slide.The stock market has forgive
Author  Beincrypto
Yesterday 01: 47
Strategy, the company once called MicroStrategy (MSTR), rose 6.9% to $111.14 on Thursday afternoon. That is its best price since June 18, which wipes out a two-month slide.The stock market has forgive
placeholder
Anthropic IPO May Top SpaceX Record: Will It Raise $100 Billion?Anthropic expects its stock market debut to match or beat the largest listing in history, according to people familiar with the matter. The bar is SpaceX, and it sits at $85.7 billion.The Claude devel
Author  Beincrypto
Yesterday 01: 48
Anthropic expects its stock market debut to match or beat the largest listing in history, according to people familiar with the matter. The bar is SpaceX, and it sits at $85.7 billion.The Claude devel
placeholder
$248 Million Mutual Fund Invests in Ripple. Does It Matter for XRP?Kinetics Internet Portfolio, a mutual fund with $248 million in assets, disclosed a direct equity stake in Ripple Labs itself rather than in XRP, according to a newly filed SEC report.The distinction
Author  Beincrypto
Yesterday 01: 50
Kinetics Internet Portfolio, a mutual fund with $248 million in assets, disclosed a direct equity stake in Ripple Labs itself rather than in XRP, according to a newly filed SEC report.The distinction
goTop
quote